Meeder Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-3,850
| Closed | -$34K | – | 2357 |
|
|
2020
Q2 | $34K | Buy |
3,850
+2,527
| +191% | +$22.3K | ﹤0.01% | 1002 |
|
|
2020
Q1 | $8K | Buy |
1,323
+589
| +80% | +$3.56K | ﹤0.01% | 1626 |
|
|
2019
Q4 | $6K | Buy |
734
+210
| +40% | +$1.72K | ﹤0.01% | 1736 |
|
|
2019
Q3 | $5K | Buy |
+524
| New | +$5K | ﹤0.01% | 1773 |
|
|
2019
Q2 | – | Sell |
-201
| Closed | -$2K | – | 2131 |
|
|
2019
Q1 | $2K | Sell |
201
-537
| -73% | -$5.34K | ﹤0.01% | 1569 |
|
|
2018
Q4 | $8K | Buy |
738
+587
| +389% | +$6.36K | ﹤0.01% | 1310 |
|
|
2018
Q3 | $3K | Sell |
151
-509
| -77% | -$10.1K | ﹤0.01% | 1411 |
|
|
2018
Q2 | $9.37K | Sell |
660
-769
| -54% | -$10.9K | ﹤0.01% | 1136 |
|
|
2018
Q1 | $27K | Buy |
1,429
+556
| +64% | +$10.5K | ﹤0.01% | 814 |
|
|
2017
Q4 | $14K | Buy |
873
+590
| +208% | +$9.46K | ﹤0.01% | 1047 |
|
|
2017
Q3 | $4K | Sell |
283
-309
| -52% | -$4.37K | ﹤0.01% | 1332 |
|
|
2017
Q2 | $5K | Sell |
592
-839
| -59% | -$7.09K | ﹤0.01% | 1207 |
|
|
2017
Q1 | $7K | Sell |
1,431
-2,773
| -66% | -$13.6K | ﹤0.01% | 962 |
|
|
2016
Q4 | $13K | Buy |
+4,204
| New | +$13K | ﹤0.01% | 713 |
|